SCHEMBL30697392

SCHEMBL30697392

NS(=O)(=O)c1ccc(CCNC(=O)CCCn2c(SCC(=O)c3ccc(Cl)c(Cl)c3)nc3ccsc3c2=O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.71
▸ RECQL P46063 2/20 0.68
▸ ALDH1A1 P00352 6/20 0.56
▸ MAPK1 P28482 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.52
▸ POLB P06746 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ NSD2 O96028 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ CA2 P00918 7/20 0.49
▸ CA12 O43570 2/20 0.49
▸ CA9 Q16790 2/20 0.49
▸ CA1 P00915 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26978421 1.00 RXFP1 (0.71) RXFP1RECQLALDH1A1MAPK1NPSR1
SCHEMBL3873997 0.83 RXFP1 (0.66) RXFP1RECQLALDH1A1MAPK1NPSR1
SCHEMBL3873519 0.78 CA2 (0.77) RXFP1RECQLALDH1A1MAPK1LMNA
SCHEMBL12791470 0.76 RXFP1 (0.57) RXFP1RECQLALDH1A1MAPK1NPSR1
SCHEMBL3866518 0.72 TP53 (0.70) RXFP1RECQLALDH1A1NPSR1KDM4E
SCHEMBL3872687 0.72 LMNA (0.75) RXFP1RECQLALDH1A1MAPK1NPSR1
SCHEMBL3871973 0.61 CA2 (0.76) RXFP1ALDH1A1KDM4EPOLBMAPT
SCHEMBL7259483 0.61 HSD17B10 (0.48) RXFP1ALDH1A1MAPTLMNAMEN1
SCHEMBL16353661 0.60 CA1 (0.76) ALDH1A1CA2CA12CA9CA1
SCHEMBL11935082 0.60 CA1 (0.90) ALDH1A1POLBCA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240351-B1 COMPOSITION FOR ENHANCING INTRA-CELLULAR NITRIC OXIDE GENERATION INST OF LIFE SCIENCES ILS (IN) 2025-08-27 — — EP claimed
EP-4240351-B1 COMPOSITION FOR ENHANCING INTRA-CELLULAR NITRIC OXIDE GENERATION INST OF LIFE SCIENCES ILS (IN) 2025-08-27 — — EP disclosed
US-20240000786-A1 COMPOSITION FOR ENHANCING INTRA-CELLULAR NITRIC OXIDE GENERATION INSTITUTE OF LIFE SCIENCES (IN) 2024-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240000786-A1 COMPOSITION FOR ENHANCING INTRA-CELLULAR NITRIC OXIDE GENERATION NOS2, NOS3, NOS1 RXFP1 1602/4885RECQL 4697/4885ALDH1A1 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback